Abstract

Epstein-Barr virus (EBV) immortalization of resting B lymphocytes (RBLs) to lymphoblastoid cell lines (LCLs) models human DNA tumor virus oncogenesis. RBL and LCL chromatin interaction maps are compared to identify the spatial and temporal genome architectural changes during EBV B cell transformation. EBV induces global genome reorganization where contact domains frequently merge or subdivide during transformation. Repressed B compartments in RBLs frequently switch to active A compartments in LCLs. LCLs gain 40% new contact domain boundaries. Newly gained LCL boundaries have strong CTCF binding at their borders while in RBLs, the same sites have much less CTCF binding. Some LCL CTCF sites also have EBV nuclear antigen (EBNA) leader protein EBNALP binding. LCLs have more local interactions than RBLs at LCL dependency factors and super-enhancer targets. RNA Pol II HiChIP and FISH of RBL and LCL further validate the Hi-C results. EBNA3A inactivation globally alters LCL genome interactions. EBNA3A inactivation reduces CTCF and RAD21 DNA binding. EBNA3C inactivation rewires the looping at the CDKN2A/B and AICDA loci. Disruption of a CTCF site at AICDA locus increases AICDA expression. These data suggest that EBV controls lymphocyte growth by globally reorganizing host genome architecture to facilitate the expression of key oncogenes.

The dynamic and temporal changes of host genome architecture during Epstein-Barr virus (EBV) transformation are not well known. Here the authors transform human primary B lymphocyte into lymphoblastoid cell lines (LCLs) with EBV and show that the host 3D genome is rewired to facilitate expression of key oncogenes.

Details

Title
A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth
Author
Wang, Chong 1 ; Liu, Xiang 2   VIAFID ORCID Logo  ; Liang, Jun 3 ; Narita, Yohei 3   VIAFID ORCID Logo  ; Ding, Weiyue 3 ; Li, Difei 3 ; Zhang, Luyao 3 ; Wang, Hongbo 3 ; Leong, Merrin Man Long 3 ; Hou, Isabella 3 ; Gerdt, Catherine 3 ; Jiang, Chang 4 ; Zhong, Qian 5   VIAFID ORCID Logo  ; Tang, Zhonghui 6 ; Forney, Carmy 7 ; Kottyan, Leah 7   VIAFID ORCID Logo  ; Weirauch, Matthew T. 7   VIAFID ORCID Logo  ; Gewurz, Benjamin E. 3   VIAFID ORCID Logo  ; Zeng, Mu-sheng 5   VIAFID ORCID Logo  ; Jiang, Sizun 8   VIAFID ORCID Logo  ; Teng, Mingxiang 2   VIAFID ORCID Logo  ; Zhao, Bo 3   VIAFID ORCID Logo 

 Brigham and Women’s Hospital and Harvard Medical School, Division of Infectious Disease, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); University of Minnesota, Department of Diagnostic and Biological Sciences, School of Dentistry, Minneapolis, USA (GRID:grid.17635.36) (ISNI:0000000419368657) 
 H. Lee Moffitt Cancer Center and Research Institute, Department of Biostatistics and Bioinformatics, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233) 
 Brigham and Women’s Hospital and Harvard Medical School, Division of Infectious Disease, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294) 
 Brigham and Women’s Hospital and Harvard Medical School, Division of Infectious Disease, Department of Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294); H. Lee Moffitt Cancer Center and Research Institute, Department of Cancer Physiology, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233) 
 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China (GRID:grid.488530.2) (ISNI:0000 0004 1803 6191) 
 Sun Yat-sen University, Zhongshan School of Medicine, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
 Cincinnati Children’s Hospital Medical Center, Center for Autoimmune Genomics and Etiology, Cincinnati, USA (GRID:grid.239573.9) (ISNI:0000 0000 9025 8099) 
 Beth Israel Deaconess Medical Center and Harvard Medical School, Center for Virology and Vaccine Research, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547) 
Pages
1598
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2789591063
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.